Ray Co. Ltd
RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry. The company offers RAYSACN Series, RAYios, RAYFace, RAYDENT Microscan, RIO Series, RAYDENT designer and tray, RAYSmiler, RAYDENT Studio, and RAYDENT Mill 4X and 5X, as well as consumables. RAY Co., Ltd. was incorporated in 2004 and is headquartered in Seongnam-si, South Korea.
Ray Co. Ltd (228670) - Total Liabilities
Latest total liabilities as of September 2025: ₩122.77 Billion KRW
Based on the latest financial reports, Ray Co. Ltd (228670) has total liabilities worth ₩122.77 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ray Co. Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Ray Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ray Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Ray Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tobii AB (publ)
F:24T
|
Germany | €900.00 Million |
|
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV
|
USA | $19.64 Million |
|
Tristar Gold
OTCQB:TSGZF
|
USA | $2.60 Million |
|
Jaanh CosmeticsInc.
KQ:219550
|
Korea | ₩17.22 Billion |
|
Jagsonpal Pharmaceuticals Limited
NSE:JAGSNPHARM
|
India | ₹461.88 Million |
|
Prostemics Co. Ltd
KQ:203690
|
Korea | ₩33.62 Billion |
|
CHA Vaccine Institute Co. Ltd.
KQ:261780
|
Korea | ₩22.26 Billion |
|
Intchains Group Limited American Depositary Shares
NASDAQ:ICG
|
USA | $40.13 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Ray Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ray Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ray Co. Ltd (2016–2024)
The table below shows the annual total liabilities of Ray Co. Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩129.80 Billion | +1.12% |
| 2023-12-31 | ₩128.36 Billion | +21.22% |
| 2022-12-31 | ₩105.89 Billion | +38.25% |
| 2021-12-31 | ₩76.59 Billion | +220.32% |
| 2020-12-31 | ₩23.91 Billion | +25.03% |
| 2019-12-31 | ₩19.12 Billion | +27.52% |
| 2018-12-31 | ₩15.00 Billion | +34.92% |
| 2017-12-31 | ₩11.12 Billion | +1.67% |
| 2016-12-31 | ₩10.93 Billion | -- |